Medical Condition News

RSS

Taking regular aspirin halves risk of hereditary cancers

Scientists including those from Queen's University have discovered that taking regular aspirin halves the risk of developing hereditary cancers.

28 Oct 2011

Enoxaparin can reduce risk of VTE in plastic surgery patients

For plastic surgery patients at high risk, treatment with the anticoagulant (blood-thinning) drug enoxaparin can reduce the risk of serious blood clot-related complications called venous thromboembolism (VTE), reports a study in the November issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

28 Oct 2011

Diabetic patients with mild kidney disease may benefit from vitamin B6 derivative

A vitamin B6 derivative may help slow or prevent the progression of mild kidney disease in patients with diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.

28 Oct 2011

Million Hearts' goal to prevent a million heart attacks and strokes in five years

In the time needed to read out loud the headline on this story, someone has died from a stroke. Every 6 seconds, someone in the world dies from stroke. The Centers for Disease Control and Prevention, in support of World Stroke Day, Oct. 29, 2011, asks Americans to take immediate action to reduce their risk for stroke.

28 Oct 2011

La Jolla Institute becomes 5th participant in novel stem cell research collaboration

The La Jolla Institute for Allergy & Immunology has become the fifth organization in the prestigious Sanford Consortium for Regenerative Medicine, joining colleagues from the Salk Institute for Biological Studies, The Scripps Research Institute, University of California, San Diego and the Sanford-Burnham Medical Research Institute in the first-of-its-kind multi-institutional stem cell research collaboration.

28 Oct 2011

Regeneron announces positive results from sarilumab Phase 2b trial on RA

Regeneron Pharmaceuticals, Inc. today announced that detailed clinical data from the positive Phase 2b portion of the seamless Phase 2/3 MOBILITY trial of sarilumab in rheumatoid arthritis (RA) will be presented at a late-breaking poster session at the upcoming American College of Rheumatology (ACR) Annual Scientific Meeting, which will take place from November 5-9 in Chicago.

28 Oct 2011

Apnex Medical's HGNS System receives CE Mark approval for treatment of OSA

Apnex Medical, Inc., has received CE Mark approval for its Hypoglossal Nerve Stimulation System for use by people who suffer from obstructive sleep apnea.

28 Oct 2011

Novel scarless surgery effectively removes skull base tumors

A technique developed by Johns Hopkins surgeons is providing a new route to get to and remove tumors buried at the base of the skull: through the natural hole behind the molars, above the jawbone and beneath the cheekbone.

27 Oct 2011

HDM and SCT increase overall survival for patients with AL amyloidosis

A team of researchers led by Boston University School of Medicine (BUSM), has found treatment of selected immunoglobulin light chain (AL) amyloidosis patients with high-dose melphalan and autologous stem cell transplantation (HDM/SCT) resulted in a high organ response rate and increased overall survival (OS), even for those patients who did not achieve a hematologic complete response.

27 Oct 2011

Microglia plays a key role in memory and learning

Immune system cells of the brain, which scavenge pathogens and damaged neurons, are also key players in memory and learning, according to new research by Duke neuroscientists.

27 Oct 2011

Innovative trial project of MD-Logic Artificial Pancreas takes place in Israel

At the initiative, and under the leadership of specialists in the Jesse Z and Sara Lea Shaffer Institute for Endocrinology and Diabetes, National Center of Childhood Diabetes, Schneider Children's Medical Center, an innovative trial project of the MD-Logic Artificial Pancreas (MDLAP) has successfully taken place in Israel.

27 Oct 2011

Annual chest radiographic screening does not reduce lung cancer mortality

In a trial that included more than 150,000 participants, those who underwent annual chest radiographic screening for up to 4 years did not have a significantly lower rate of death from lung cancer compared to participants who were not screened, according to a study in the November 2 issue of JAMA.

27 Oct 2011

Researchers uncover molecular pathway critical to cardiac arrhythmia

University of Maryland School of Medicine researchers have uncovered a previously unknown molecular pathway that is critical to understanding cardiac arrhythmia and other heart muscle problems.

27 Oct 2011

Penn Nursing experts available to discuss stories on American Diabetes Month

Diabetes specialists at the University of Pennsylvania School of Nursing are available to talk with media for stories on American Diabetes Month.

27 Oct 2011

U of A researchers discover potential new drug target for MS

Medical researchers at the University of Alberta have discovered a potential new drug target for Multiple Sclerosis that could prevent physical disability associated with the disease, once a new drug is developed.

27 Oct 2011

Medtronic initiates Symplicity System clinical study in treatment-resistant hypertension

Medtronic Inc. announced today the start of SYMPLICITY HTN-3, the company's U.S. clinical trial of the Symplicity Renal Denervation System for treatment-resistant hypertension.

From Medtronic 27 Oct 2011

Nanoparticles could help increase retention of osteoarthritis drugs in knee cavity

A novel study demonstrates that using nanoparticles to deliver osteoarthritis drugs to the knee joint could help increase the retention of the drug in the knee cavity, and therefore reduce the frequency of injections patients must receive.

27 Oct 2011

E. coli asparaginase linked to relapses in ALL patients with special form of ATF5 gene

One of the causes of resistance to cancer treatment in children is now beginning to be elucidated. Acute lymphoblastic leukemia patients with a particular form of the ATF5 gene are at higher risk of having a relapse when treated with E. coli asparaginase, a key chemotherapy drug for this type of leukemia.

27 Oct 2011

Scripps researcher receives U-M's Eric J. Topol Professorship in Cardiovascular Medicine

The University of Michigan Medical School today announced the establishment of the Eric J. Topol Professorship in Cardiovascular Medicine. A world-renowned cardiologist, Dr. Topol is currently chief academic officer at Scripps Health and a senior cardiologist practitioner at Scripps Clinic.

27 Oct 2011

Cancer experts say needs of younger patients slighted

Physicians and researchers acknowledge that for decades, the needs of adolescents and young adults with cancer have been slighted. They frequently receive inconsistent treatment and follow-up care, and clinical trials and research focused on this age group have been scarce, according to oncologists and a report by the National Cancer Institute.

27 Oct 2011

Medical Condition News

Taking regular aspirin halves risk of hereditary cancers

Enoxaparin can reduce risk of VTE in plastic surgery patients

Diabetic patients with mild kidney disease may benefit from vitamin B6 derivative

Million Hearts' goal to prevent a million heart attacks and strokes in five years

La Jolla Institute becomes 5th participant in novel stem cell research collaboration

Regeneron announces positive results from sarilumab Phase 2b trial on RA

Apnex Medical's HGNS System receives CE Mark approval for treatment of OSA

Novel scarless surgery effectively removes skull base tumors

HDM and SCT increase overall survival for patients with AL amyloidosis

Microglia plays a key role in memory and learning

Innovative trial project of MD-Logic Artificial Pancreas takes place in Israel

Annual chest radiographic screening does not reduce lung cancer mortality

Researchers uncover molecular pathway critical to cardiac arrhythmia

Penn Nursing experts available to discuss stories on American Diabetes Month

U of A researchers discover potential new drug target for MS

Medtronic initiates Symplicity System clinical study in treatment-resistant hypertension

Nanoparticles could help increase retention of osteoarthritis drugs in knee cavity

E. coli asparaginase linked to relapses in ALL patients with special form of ATF5 gene

Scripps researcher receives U-M's Eric J. Topol Professorship in Cardiovascular Medicine

Cancer experts say needs of younger patients slighted

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News